Trials / Completed
CompletedNCT00589225
Primary Hyperoxaluria Mutation Genotyping
Correlation of Disease Expression With Specific Genetic Mutations in Primary Hyperoxaluria
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 902 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.
Detailed description
During your study visit, we will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in Primary Hyperoxaluria by comparing it with the structure of genes in normal individuals, patients with Primary Hyperoxaluria, and family members of Primary Hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hour urine test may also be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Genetic Analysis | We will draw one tube of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. |
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2008-01-09
- Last updated
- 2016-07-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00589225. Inclusion in this directory is not an endorsement.